PALO ALTO, Calif., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Scilex Bio, a controlling interest of joint venture by Scilex Holding Company (SCLX) (Nasdaq: SCLX, “Scilex” or “Company”) with IPMC Company, a ...
NEW YORK, March 11, 2026 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) today announced that Isobel Coleman has been named Chief Executive Officer, effective March 23, 2026. Coleman ...
This morning Altoida, a digital platform that uses artificial intelligence and machine learning to help predict Alzheimer’s disease, closed a $6.3 million Series A funding round. M Ventures led the ...
And now they’re launching it by way of their startup, ProFoldBio — one of nearly 70 startups that have emerged from UCSB’s New Venture Program — making the software available to other researchers in ...
PALO ALTO, Calif., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”) and IPMC Company, a representative company of the Bio Innovation Consortium (“BOIC”), ...
Alan J. Patricof, one of the defining figures of modern venture capital and Chairperson and co-founder of Primetime Partners, ...
Coleman's global leadership and deep expertise across philanthropy, private sector, and public service position the ADDF to define the next phase of Alzheimer's science NEW YORK, March 11, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results